US is the best place for drug companies to invest, says boss of London-based GSK
PositiveFinancial Markets

- Emma Walmsley, CEO of GSK, has stated that the United States is the premier destination for pharmaceutical investment, citing its leadership in drug and vaccine launches. This assertion places additional pressure on the UK government to enhance its appeal to drug companies.
- Walmsley's comments underscore GSK's strategic focus on expanding its operations in the US market, reflecting a commitment to capitalize on the favorable business environment and growth opportunities available there.
- This development highlights a broader trend where pharmaceutical companies are increasingly prioritizing markets like the US and China for investment, as evidenced by recent initiatives in China to include major drug firms in its innovative drug catalog, indicating a competitive landscape in global healthcare.
— via World Pulse Now AI Editorial System







